Risperidone hydrochlorideCAS# 666179-74-4 |
2D Structure
- Methylcobalamin
Catalog No.:BCC5188
CAS No.:13422-55-4
- TPT-260 Dihydrochloride
Catalog No.:BCC5172
CAS No.:2076-91-7
- Miglustat hydrochloride
Catalog No.:BCC5186
CAS No.:210110-90-0
- Tirapazamine
Catalog No.:BCC5184
CAS No.:27314-97-2
- Amifampridine
Catalog No.:BCC5185
CAS No.:54-96-6
- Miglustat
Catalog No.:BCC5187
CAS No.:72599-27-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 666179-74-4 | SDF | Download SDF |
PubChem ID | 9889802 | Appearance | Powder |
Formula | C23H28ClFN4O2 | M.Wt | 446.95 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in DMSO | ||
Chemical Name | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one;hydrochloride | ||
SMILES | CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F.Cl | ||
Standard InChIKey | OCBZQKQWVUTYDN-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C23H27FN4O2.ClH/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22;/h5-6,14,16H,2-4,7-13H2,1H3;1H | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Risperidone hydrochloride Dilution Calculator
Risperidone hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.2374 mL | 11.1869 mL | 22.3739 mL | 44.7477 mL | 55.9347 mL |
5 mM | 0.4475 mL | 2.2374 mL | 4.4748 mL | 8.9495 mL | 11.1869 mL |
10 mM | 0.2237 mL | 1.1187 mL | 2.2374 mL | 4.4748 mL | 5.5935 mL |
50 mM | 0.0447 mL | 0.2237 mL | 0.4475 mL | 0.895 mL | 1.1187 mL |
100 mM | 0.0224 mL | 0.1119 mL | 0.2237 mL | 0.4475 mL | 0.5593 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Risperidone Hcl(R 64 766 Hcl) is a serotonin 5-HT2 receptor blocker(Ki= 0.16 nM) and a potent dopamine D2 receptor antagonist(Ki= 1.4 nM).
- RU 24969
Catalog No.:BCC5423
CAS No.:66611-26-5
- Boc-Phenylalaninol
Catalog No.:BCC2718
CAS No.:66605-57-0
- Agaric acid
Catalog No.:BCC9216
CAS No.:666-99-9
- Dihydrorotenone
Catalog No.:BCN2726
CAS No.:6659-45-6
- Forskolin
Catalog No.:BCN2332
CAS No.:66575-29-9
- Tsugafolin
Catalog No.:BCN4026
CAS No.:66568-97-6
- ent-3beta-Hydroxykaur-16-en-19-oic acid
Catalog No.:BCN6472
CAS No.:66556-91-0
- CL 218872
Catalog No.:BCC7162
CAS No.:66548-69-4
- Augustifolin
Catalog No.:BCN3232
CAS No.:66548-01-4
- Ansamitocin P-3
Catalog No.:BCN8373
CAS No.:66547-09-9
- Propacetamol hydrochloride
Catalog No.:BCC9129
CAS No.:66532-86-3
- Benzoin isopropyl ether
Catalog No.:BCC8856
CAS No.:6652-28-4
- Risperidone mesylate
Catalog No.:BCC4206
CAS No.:666179-96-0
- 2',4'-Dihydroxy-3,7':4,8'-diepoxylign-7-ene
Catalog No.:BCN6645
CAS No.:666250-52-8
- GW842166X
Catalog No.:BCC4413
CAS No.:666260-75-9
- Biotin Hydrazide
Catalog No.:BCC3582
CAS No.:66640-86-6
- Acetyl Angiotensinogen (1-14), porcine
Catalog No.:BCC1023
CAS No.:66641-26-7
- N-trans-Feruloyltyramine
Catalog No.:BCN4213
CAS No.:66648-43-9
- N-Feruloyloctopamine
Catalog No.:BCN4604
CAS No.:66648-44-0
- N-p-Coumaroyloctopamine
Catalog No.:BCN4603
CAS No.:66648-45-1
- Ethyl caffeate
Catalog No.:BCN4214
CAS No.:102-37-4
- 4',5-Dihydroxyflavone
Catalog No.:BCN4215
CAS No.:6665-67-4
- Galangin 3-methyl ether
Catalog No.:BCN3681
CAS No.:6665-74-3
- 5,7-Diacetoxyflavone
Catalog No.:BCN4216
CAS No.:6665-78-7
Extractive colorimetric method for the determination of dothiepin hydrochloride and risperidone in pure and in dosage forms.[Pubmed:18670108]
Chem Pharm Bull (Tokyo). 2008 Aug;56(8):1092-6.
Three rapid, simple, reproducible and sensitive extractive colorimetric methods (A--C) for assaying dothiepin hydrochloride (I) and risperidone (II) in bulk sample and in dosage forms were investigated. Methods A and B are based on the formation of an ion pair complexes with methyl orange (A) and orange G (B), whereas method C depends on ternary complex formation between cobalt thiocyanate and the studied drug I or II. The optimum reaction conditions were investigated and it was observed the calibration curves resulting from the measurements of absorbance concentration relations of the extracted complexes were linear over the concentration range 0.1--12 microg ml(-1) for method A, 0.5--11 mug ml(-1) for method B, and 3.2--80 microg ml(-1) for method C with a relative standard deviation (RSD) of 1.17 and 1.28 for drug I and II, respectively. The molar absorptivity, Sandell sensitivity, Ringbom optimum concentration ranges, and detection and quantification limits for all complexes were calculated and evaluated at maximum wavelengths of 423, 498, and 625 nm, using methods A, B, and C, respectively. The interference from excipients commonly present in dosage forms and common degradation products was studied. The proposed methods are highly specific for the determination of drugs I and II, in their dosage forms applying the standard additions technique without any interference from common excipients. The proposed methods have been compared statistically to the reference methods and found to be simple, accurate (t-test) and reproducible (F-value).
New-onset diabetic ketoacidosis induced by the addition of perospirone hydrochloride in a patient treated with risperidone.[Pubmed:17301517]
Intern Med. 2007;46(4):199-200. Epub 2007 Feb 15.
A 32-year-old man with a family history of type 2 diabetes mellitus presented with circulatory collapse and deep coma after 9 days of treatment with perospirone hydrochloride, a recently developed atypical antipsychotic agent available only in Japan. The new drug had been added to the long-standing treatment with risperidone. Diagnosed with diabetic ketoacidosis, he was given insulin and saline with discontinuation of all antipsychotics. Ultimately, diabetes was controlled by dietary therapy alone despite reintroduction of risperidone. The risk of new-onset diabetic ketoacidosis in patients with diabetic risk factors who are taking perospirone hydrochloride or other atypical antipsychotics should be kept in mind.